title: Allergic bronchopulmonary aspergillosis and omalizumab.
authors.affiliation: Service de Pneumologie et d’Immuno-Allergologie, Hôpital Calmette, University Lille 2, 1421 bd. Leclercq, CHRU, Lille, France. i-tillie@chru-lille.fr
authors.forename: I
authors.initials: I
authors.lastname: Tillie-Leblond
authors.forename: P
authors.initials: P
authors.lastname: Germaud
authors.forename: C
authors.initials: C
authors.lastname: Leroyer
authors.forename: L
authors.initials: L
authors.lastname: Tétu
authors.forename: F
authors.initials: F
authors.lastname: Girard
authors.forename: G
authors.initials: G
authors.lastname: Devouassoux
authors.forename: J-P
authors.initials: JP
authors.lastname: Grignet
authors.forename: A
authors.initials: A
authors.lastname: Prudhomme
authors.forename: D
authors.initials: D
authors.lastname: Dusser
authors.forename: B
authors.initials: B
authors.lastname: Wallaert
mesh_terms: D000328:Adult; D000368:Aged; D018927:Anti-Asthmatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab; D011239:Prednisolone / Q000627:therapeutic use
chemical_list: D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D011239:Prednisolone